NCT00312923View on ClinicalTrials.gov

Preliminary Study of Safety and Efficacy of Policosanol

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
DyslipidemiaHIV Infections
Interventions
DRUG

Policosanol

20 mg of policosanol in capsular form daily

DIETARY_SUPPLEMENT

Placebo

Two capsules of 10 mg of microcrystalline cellulose daily

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Rush University Medical Center

OTHER

NCT00312923 - Preliminary Study of Safety and Efficacy of Policosanol | Biotech Hunter | Biotech Hunter